Pharmacovigilance
DSA offers a range of pharmacovigilance services to DSA Clients. Each client relationship is different, and services offered can range from DSA holding all of the Canadian PV responsibility to a shared responsibility with the client or other parties. Our services include:
- Writing SOPs to govern the Canadian pharmacovigilance program.
- Establishing safety profiles
- Preparing agreements such as Safety Data Exchange Agreements for Canada or Pharmacovigilance Agreements
- Reporting domestic serious unexpected and unexpected adverse drug reactions (ADR) to Health Canada
- Reporting foreign serious unexpected adverse drug reactions (ADR) to Health Canada
- Reporting Lack of Efficacy for new drugs
- Monitoring and Reporting Foreign Actions to comply with C.01.050
- Monitoring Regulatory Authorities Sources
- Monitoring Scientific Literature
- Preparing Annual Summary Reports or Periodic Safety Update Reports (PSUR)
- Preparing Annual Periodic Benefit-Risk Evaluation Report (PBRER)
- Preparing Issue Related Summary Reports
- Conducting Signal Detection Reviews
- Conducting PV Self-Inspections or PV Audits of other service providers.
- Qualified Healthcare Practitioners on staff to meet Canadian requirements

Contact us to find out more about our regulatory consulting services or download a free copy of our DSA Whitepaper on marketing a health care product in Canada.



